No products in the cart.
Levetiracetam Sustained-release Tablets 0.5g Low price wholesale
$2.00
Levetiracetam Sustained-release Tablets (0.5g, 30-count) are developed for neurological and antiepileptic research. Manufactured by Zhejiang Sameer Pharmaceutical Co., Ltd., this product is authorized under Chinese NMPA registration H20234573. Suitable for wholesale and retail supply, strictly for laboratory and experimental use.?? For research use only.?Please consult staff for other specifications and uses?
Description
Levetiracetam is a second-generation antiepileptic agent used in research for its ability to modulate neurotransmitter release by binding to synaptic vesicle protein SV2A. This sustained-release formulation provides prolonged plasma levels in experimental models, supporting pharmacokinetic and neurobehavioral studies.
Levetiracetam Sustained-release Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Levetiracetam Sustained-release Tablets |
| Active Ingredient | Levetiracetam |
| CAS Number | 102767-28-2 |
| Molecular Formula | C8H14N2O2 |
| Molecular Weight | 170.21 g/mol |
| Strength | 0.5g (500mg) per tablet |
| Dosage Form | Sustained-release tablet |
| Packaging | 30 tablets per bottle/box |
| Approval Number | H20234573 (NMPA, China) |
| Product Code | 86904565000430 |
| Manufacturer | Zhejiang Sameer Pharmaceutical Co., Ltd. |
| Storage Conditions | Store in a cool, dry place; protect from light |
| Use Category | Laboratory research only |
Levetiracetam Sustained-release Mechanism of Action
Levetiracetam selectively binds to SV2A (synaptic vesicle protein 2A), modulating calcium release and neurotransmission. It reduces neuronal excitability and seizure-like activity in vitro and in vivo, without affecting normal CNS function. The sustained-release form allows for steady plasma levels in long-duration studies.
Research Applications
Epilepsy and Seizure Models: Widely used in rodent and primate models for partial-onset seizure investigations.
Pharmacokinetics: Ideal for evaluating slow-release plasma profiles and drug half-life studies.
Neuroprotection: Explored for potential neuroprotective effects against excitotoxicity and oxidative stress.
Behavioral Neuroscience: Analyzed in memory, motor coordination, and anxiety-related assays.
levetiracetam, levetiracetam sustained-release, levetiracetam tablets 0.5g, CAS 102767-28-2, epilepsy research tablets, SV2A modulator, antiepileptic research drug, Zhejiang Sameer Pharmaceutical, lab-grade levetiracetam, levetiracetam wholesale, extended-release seizure medication, neuroscience lab supply
Research Use Disclaimer
This product is intended strictly for laboratory research purposes only. It is not approved for clinical, therapeutic, or veterinary use. All buyers must adhere to applicable regulations governing research chemicals and controlled substances.
Additional information
| Weight | 1 kg |
|---|---|
| Dimensions | 28 × 23 × 28 cm |
Q1: What is the difference between immediate-release and sustained-release Levetiracetam?
A1: Sustained-release tablets offer extended drug release over time, allowing for longer exposure and reduced dosing frequency in long-term research studies.
Q2: Is this formulation suitable for human or veterinary use?
A2: No. This product is strictly intended for laboratory research use only, not for human or clinical application.
Q3: Can you provide COA and SDS documentation?
A3: Yes, Certificates of Analysis and Safety Data Sheets are available upon request for all wholesale orders.
Q4: What’s the storage recommendation?
A4: Store in a dry, cool place, ideally below 25°C, away from moisture and direct sunlight.
Q5: What are the primary research uses of Levetiracetam?
A5: Seizure threshold testing, SV2A receptor binding studies, anti-epileptic mechanism validation, and chronic neurological assessments.
Related products
Nicergoline Tablets 10?mg Low price wholesale
Nicergoline Tablets (brand: Dongyao / Shouning) contain 10?mg nicergoline per tablet, 30 tablets per box. Manufactured by Shandong Fangming Pharmaceutical Group Co., Ltd. and approved under NMPA H20103155. A semi?synthetic ergo derivative that improves cerebral and peripheral circulation, inhibits platelet aggregation, and supports neuroprotection. Suitable for laboratory research in cerebrovascular models, cognitive function studies, and neurodegeneration assays.?? Strictly for laboratory research use only.?Please consult staff for other specifications and uses?
$5.00Pregabalin Capsules SCPC 75?mg Wholesale Price Comparison
Pregabalin Capsules 75?mg ×?8 are used in laboratory research related to neuropathic pain, epilepsy, and anxiety disorders. This CNS-active molecule is a GABA analogue with selective activity at voltage-gated calcium channels. Manufactured by Sichuan Pharmaceutical Formulation Co., Ltd., and approved under NMPA registration H20233922.?? Strictly for laboratory research use only.?Please consult staff for other specifications and uses?
$2.00Oxcarbazepine Tablets 300?mg Low price wholesale
Oxcarbazepine Tablets 300mg are formulated for scientific and preclinical research into neurological disorders, particularly epilepsy and seizure-related conditions. Manufactured by Chongqing Synrex Pharmaceutical Co., Ltd., this product is approved under NMPA H20244663 and is ideal for use in controlled laboratory settings.?? Strictly for laboratory research use only.?Please consult staff for other specifications and uses?
$2.00Sodium Valproate Tablets 200?mg Low price wholesale
Sodium Valproate Tablets (brand: Dongfangming / Dianjianping) contain 200?mg sodium valproate per tablet, 30 tablets per bottle. Manufactured by Shandong Fangming Pharmaceutical Group Co., Ltd., approved under NMPA H37022627. A widely used anticonvulsant and mood-stabilizing agent ideal for laboratory use in epilepsy, bipolar disorder, migraine, and neurochemical studies based on preclinical models.?? Strictly for laboratory research use only.?Please consult staff for other specifications and uses?
$3.00
Reviews
There are no reviews yet.